Skip to main content
SpringerLink
Log in

Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

This study aims to investigate the expression and significance of GOLPH3 in human gastric cancer progression and prognosis. Using immunohistochemistry (IHC) and real-time reverse transcriptase polymerase chain reaction assay, we identified abnormally elevated expression of GOLPH3 in gastric cancer tissues compared to paired normal stomach mucosa tissues in 40 patients. In addition, the enzyme-linked immunosorbent assay (ELISA) was used to quantify serum GOLPH3 concentrations in the same 40 gastric cancer patients and 40 healthy individuals. ELISA revealed significantly higher serum concentrations of GOLPH3 in gastric cancer patients compared to healthy individuals (p = 0.002). In order to investigate the correlations between GOLPH3 and the clinicopathological features of gastric cancer, the expression of GOLPH3 in 123 gastric cancer patients were detected by IHC, and the results showed that overexpression of GOLPH3 was associated with the size of the tumor (p = 0.013), histological grade (p = 0.002), depth of invasion (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.018), and TNM stage (p < 0.001). Kaplan–Meier survival analysis showed that high GOLPH3 expression exhibited a significant correlation with poor prognosis for gastric cancer patients. Further, Cox multivariate analysis indicated that GOLPH3 expression level was an independent prognostic factor for patients after radical resection. In conclusion, the overexpression of GOLPH3 is closely related to the progression of gastric cancer and might be regarded as an independent predictor of poor prognosis for gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–15. doi:10.1016/S0140-6736(03)13975-X.

    Article  PubMed  Google Scholar 

  2. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71:127–64. doi:10.1016/j.critrevonc.2009.01.004.

    Article  PubMed  Google Scholar 

  3. Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol. 2009;10:609–22. doi:10.1038/nrm2748.

    Article  PubMed  CAS  Google Scholar 

  4. Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, Sim R, Wiharto PA, Galbraith KA, Madhavarapu S, Fuchs GJ, Meerloo T, Farquhar MG, Zhou H, Field SJ. GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell. 2009;139:337–51. doi:10.1016/j.cell.2009.07.052.

    Article  PubMed  CAS  Google Scholar 

  5. Bell AW, Ward MA, Blackstock WP, Freeman HN, Choudhary JS, Lewis AP, Chotai D, Fazel A, Gushue JN, Paiement J, Palcy S, Chevet E, Lafrenière-Roula M, Solari R, Thomas DY, Rowley A, Bergeron JJ. Proteomics characterization of abundant Golgi membrane proteins. J Biol Chem. 2001;276:5152–65. doi:10.1074/jbc.M006143200.

    Article  PubMed  CAS  Google Scholar 

  6. Wu CC, Taylor RS, Lane DR, Ladinsky MS, Weisz JA, Howell KE. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic. 2000;1:963–75. doi:10.1111/j.1600-0854.2000.11206.x.

    PubMed  CAS  Google Scholar 

  7. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature. 2009;459:1085–90. doi:10.1038/nature08109.

    Article  PubMed  CAS  Google Scholar 

  8. Scott KL, Chin L. Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis. Clin Cancer Res. 2010;16:2229–34. doi:10.1158/1078-0432.CCR-09-1695.

    Article  PubMed  CAS  Google Scholar 

  9. Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, Song LB, Song M. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med. 2012;10:168. doi:10.1186/1479-5876-10-168.

    Article  PubMed  Google Scholar 

  10. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med. 2008;6:32. doi:10.1186/1479-5876-6-32.

    Article  PubMed  Google Scholar 

  11. Tu L, Liu Z, He X, He Y, Yang H, Jiang Q, Xie S, Xiao G, Li X, Yao K, Fang W. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Mol Cancer. 2010;9:78. doi:10.1186/1476-4598-9-78.

    Article  PubMed  Google Scholar 

  12. Liu Z, Li L, Yang Z, Luo W, Li X, Yang H, Yao K, Wu B, Fang W. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer. 2010;10:270. doi:10.1186/1471-2407-10-270.

    Article  PubMed  Google Scholar 

  13. Zhu X-D, Zhang J-B, Zhuang P-Y, Zhu H-G, Zhang W, Xiong Y-Q, Wu W-Z, Wang L, Tang Z-Y, Sun H-C. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. 2008;26:2707–16. doi:10.1200/JCO.2007.15.6521.

    Article  PubMed  Google Scholar 

  14. Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol. 2001;19:3210–8.

    PubMed  CAS  Google Scholar 

  15. Hennessy BT, Hanrahan EO, Daly PA. Non-Hodgkin lymphoma: an update. Lancet Oncol. 2004;5:341–53.

    Article  PubMed  Google Scholar 

  16. Wang JH, Chen XT, Wen ZS, Zheng M, Deng JM, Wang MZ, Lin HX, Chen K, Li J, Yun JP, Luo RZ, Song LB. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. Plos One. 2012;7:e45622. doi:10.1371/journal.pone.0045622.

    Article  PubMed  CAS  Google Scholar 

  17. Zhou J, Xu T, Qin R, Yan Y, Chen C, Chen Y, Yu H, Xia C, Lu Y, Ding X, Wang Y, Cai X, Chen J. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J Neurooncol. 2012;110:195–203. doi:10.1007/s11060-012-0970-9

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Hepatobiliary Pancreatic Center, The Third Hospital Affiliated to Nantong University, No. 585, Xingyuan North Road, Wuxi, 214041, Jiangsu Province, China

    Ben-Shun Hu, Hao Hu, Cong-Yuan Zhu, Yuan-Long Gu & Jian-Ping Li

  2. Department of General Surgery, Northern Jiangsu People’s Hospital, No. 98, Nantong Road, Yangzhou, 225000, Jiangsu Province, China

    Ben-Shun Hu

Authors
  1. Ben-Shun Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hao Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cong-Yuan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuan-Long Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jian-Ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuan-Long Gu or Jian-Ping Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, BS., Hu, H., Zhu, CY. et al. Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer. Tumor Biol. 34, 515–520 (2013). https://doi.org/10.1007/s13277-012-0576-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-012-0576-z

Keywords

Search

Navigation